Company news
Crescent Biopharma, Inc. news in 2025
Crescent Biopharma, Inc.'s news releases, calls and decks from 2025, newest first.
Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics
December 4, 2025
Crescent Biopharma Announces Transformational Partnership with Kelun-Biotech and $185 Million Private Placement, Accelerating and Expanding Global Pipeline of Next Generation Therapeutics for Solid Tumors
December 3, 2025
Crescent Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights
November 6, 2025
Crescent Biopharma to Present at November Investor Conferences
November 5, 2025
Crescent Biopharma to Present Preclinical Data for CR-001, a PD-1 x VEGF Bispecific Antibody, at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
November 3, 2025
Crescent Biopharma to Present at September Investor Conferences
August 28, 2025
Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights
July 30, 2025
Crescent Biopharma Appoints Jan Pinkas, Ph.D., as Chief Scientific Officer
July 8, 2025
Decks in 2025
- Investor Presentation (December 2025)
Investor deck · 53 slides · Dec 4, 2025
- Glycomimetics — Merger or Acquisition (April 2025)
Merger or acquisition · 27 slides · Apr 3, 2025
- Glycomimetics — Merger or Acquisition (February 2025)
Merger or acquisition · 27 slides · Feb 28, 2025
- Glycomimetics — Merger or Acquisition (January 2025)
Merger or acquisition · 27 slides · Jan 13, 2025